CJC-1295 & GHRP-2 Blend – Combined GHRH & GHS Receptor Research
The CJC-1295 & GHRP-2 Blend provides a robust framework for studying neuroendocrine signaling. By pairing a GHRH analog with a potent GHRP hexapeptide, researchers can observe how concurrent receptor signaling influences the intensity and duration of growth hormone pulses in experimental models.
Synergistic Mechanism:
- CJC-1295 (The Signal): As a tetrasubstituted analog of GHRH (1-29), CJC-1295 binds to GHRH receptors in the anterior pituitary. This version is formulated without DAC, ensuring a natural, pulsatile signaling profile that mimics endogenous rhythms.
- GHRP-2 (The Trigger): A synthetic hexapeptide that acts as a high-affinity agonist for the GHS-R1a (ghrelin) receptors. It triggers the immediate release of GH and has been researched for its ability to produce a more substantial surge than GHRH alone.
Key Research Implications:
- Dual Pathway Activation: This blend targets two distinct receptor populations (GHRH-R and GHS-R1a), allowing for the study of additive hormonal output and receptor crosstalk within the central nervous system.
- Somatotroph Proliferation: Research suggests that repeated exposure to these analogs may lead to the proliferation of GH-producing cells in the pituitary gland, a key area of interest for age-related decline studies.
- Metabolic & Muscle Synthesis: GHRP-2 is noted for its potential to reduce muscle atrophy and enhance protein deposition, while CJC-1295 supports lean body mass and bone function research.
- Pharmacokinetic Study: This blend is ideal for researchers evaluating the metabolic clearance and stability of tetrasubstituted peptides in the absence of a Drug Affinity Complex (DAC).
Elite Peptide Supply ensures that this blend is synthesized to the highest purity standards. Our CJC-1295 / GHRP-2 stack is a reliable tool for mapping the complex interactions of the human growth hormone axis.
Reviews
There are no reviews yet.